<DOC>
	<DOCNO>NCT02032134</DOCNO>
	<brief_summary>The increase need blood component increasingly careful donor selection procedure , make availability blood component reduce , particular platelet currently administer preferably `` fresh '' cryopreserved , emergency condition . Exceeding limit spread use cryopreserved platelet common clinical practice , might help clinician avoid waste valuable product face period particular shortage donor Some study already publish literature last decade ( 1,2 ) demonstrate safety efficacy autologous cryopreserved platelet . The main objective propose study evaluate efficacy safety platelet , cryopreserved DMSO use new method , patient severe thrombocytopenia . This vivo phase study availability efficacy cryopreserved platelet assess vitro .</brief_summary>
	<brief_title>Protocol Infusion Buffy Coat-derived Cryopreserved Platelets Patients With Severe Thrombocytopenia</brief_title>
	<detailed_description>The primary objective study evaluate hemostatic efficacy safety recipient platelet obtain buffy coat multiple donor ( five ) , cryopreserved DMSO use new patent method , 9 month collection . Further goal registration related- adverse event ( idiosyncrasy , allergy , toxicity )</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Dimethyl Sulfoxide</mesh_term>
	<criteria>Cryopreserved buffy coat pool platelet infuse , thaw , inpatient U.O . Hematology Policlinic `` P. Giaccone '' Palermo , fall one follow category : Stable clinical condition complication platelet ≤ 10,000/microliter ; With active bleed ≤ 20,000 platelets/microliter ; In presence : high blood pressure , high fever , rapid drop platelet , infection , chemotherapy , coagulation abnormality ≤ 20,000 platelets/microliter . Patients Suffering congenital immunodeficiency Allogeneic bone marrow transplant candidate Bone Marrow Donors transplantation Undergoing bone marrow transplant Suffering Hodgkin 's disease treat purine analogue ( Fludarabine , cladribine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Cryopreserved platelet , thrombocytopenia , DMSO</keyword>
</DOC>